E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors

Revathi Rajkumar, Bhagyalekshmi N, Ramesh M, Santhosh R Pillai.


Abstract
Background: Proton pump inhibitors (PPI) are most commonly prescribed medications in the world which are highly effective drugs in treatment of upper gastrointestinal disorders, but there are concerns regarding its long term use.

Aim and Objective: To assess the pattern of reported adverse drug reactions (ADR) in patients with long term use of PPI and to estimate the frequency of adverse drug effects.

Materials and Methods: A study conducted as an observational study among 100 consecutive patients who attended the medical-gastro inpatient and outpatient department on treatment with PPI for more than 4 months, according to inclusion and exclusion criteria. After attaining the written informed consent, data regarding patientÂ’s demographic details, occupational status, addictions, co-morbidities, and lab investigations were recorded in pre-prepared proforma after interviewing the patient and referring the case sheet. Details including PPI used and per day dose of the drug with any ADR developed were noted. Data collected were analyzed using appropriate statistical method. Categorical variables are expressed as frequency (percentage) and continuous variables as mean (standard deviation). Chi-square test was used to find out the association between PPI and ADR.

Results: Out of 100 study participants, 57% case reported ADR which included 19 cases (33.3%) of hypomagnesemia, 8 cases (14%) each of hypocalcemia, and hyperkalemia, 7 cases (12.3%) of anemia, and 5 cases (8.9%) of acute kidney injury. Out of the 57 reported adverse events, 29 (50.9%) were caused by Rabeprazole followed by 18 (31.6%) by Pantoprazole, then Esomeprazole: 8 (14%), and least by Omeprazole (3.5%).

Conclusion: Long-term use of PPI can lead to various ADR which requires the withdrawal of drug. Since PPIs are easily available without prescriptions, self-medication with PPIs are increasing alarmingly. With every antibiotic one PPI is always prescribed, as a result, there is irrational use of PPIs which is of concern and requires attention. These adverse events could be reduced by preventing self-medication of long duration and reducing the irrational prescribing of PPIs. Doctors should be sensitized about the ADRs. The patient should be educated about the long-term adverse effects of PPIs.

Key words: Proton Pump Inhibitors; Long-Term Use; Adverse Drug Reaction


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Revathi Rajkumar
Articles by Bhagyalekshmi N
Articles by Ramesh M
Articles by Santhosh R Pillai
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Rajkumar R, N B, M R, Pillai SR. An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors. Natl J Physiol Pharm Pharmacol. 2022; 12(4): 477-480. doi:10.5455/njppp.2022.12.09326202108102021


Web Style

Rajkumar R, N B, M R, Pillai SR. An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors. https://www.njppp.com/?mno=120199 [Access: March 14, 2024]. doi:10.5455/njppp.2022.12.09326202108102021


AMA (American Medical Association) Style

Rajkumar R, N B, M R, Pillai SR. An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors. Natl J Physiol Pharm Pharmacol. 2022; 12(4): 477-480. doi:10.5455/njppp.2022.12.09326202108102021



Vancouver/ICMJE Style

Rajkumar R, N B, M R, Pillai SR. An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors. Natl J Physiol Pharm Pharmacol. (2022), [cited March 14, 2024]; 12(4): 477-480. doi:10.5455/njppp.2022.12.09326202108102021



Harvard Style

Rajkumar, R., N, . B., M, . R. & Pillai, . S. R. (2022) An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors. Natl J Physiol Pharm Pharmacol, 12 (4), 477-480. doi:10.5455/njppp.2022.12.09326202108102021



Turabian Style

Rajkumar, Revathi, Bhagyalekshmi N, Ramesh M, and Santhosh R Pillai. 2022. An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors. National Journal of Physiology, Pharmacy and Pharmacology, 12 (4), 477-480. doi:10.5455/njppp.2022.12.09326202108102021



Chicago Style

Rajkumar, Revathi, Bhagyalekshmi N, Ramesh M, and Santhosh R Pillai. "An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 477-480. doi:10.5455/njppp.2022.12.09326202108102021



MLA (The Modern Language Association) Style

Rajkumar, Revathi, Bhagyalekshmi N, Ramesh M, and Santhosh R Pillai. "An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors." National Journal of Physiology, Pharmacy and Pharmacology 12.4 (2022), 477-480. Print. doi:10.5455/njppp.2022.12.09326202108102021



APA (American Psychological Association) Style

Rajkumar, R., N, . B., M, . R. & Pillai, . S. R. (2022) An observational study on adverse drug reaction profile in patients on long-term treatment with proton pump inhibitors. National Journal of Physiology, Pharmacy and Pharmacology, 12 (4), 477-480. doi:10.5455/njppp.2022.12.09326202108102021